SMS LIFESCIENCES INDIA
|
SMS LIFESCIENCES INDIA Last 5 Year Financial Ratios History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Operational & Financial Ratios | |||||
| Earnings Per Share (Rs) | 66.51 | 30.08 | 37.91 | 83.76 | 44.84 |
| CEPS(Rs) | 111.56 | 70.34 | 73.32 | 116.78 | 70.84 |
| DPS(Rs) | 1.50 | 1.50 | 1.50 | 1.50 | 1.50 |
| Book NAV/Share(Rs) | 650.15 | 584.84 | 557.71 | 503.53 | 427.40 |
| Tax Rate(%) | 28.47 | 35.74 | 31.43 | 22.70 | 30.72 |
| Margin Ratios | |||||
| Core EBITDA Margin(%) | 11.68 | 9.21 | 8.05 | 8.88 | 10.25 |
| EBIT Margin(%) | 9.06 | 5.93 | 6.55 | 10.02 | 8.19 |
| Pre Tax Margin(%) | 6.79 | 2.90 | 4.63 | 8.42 | 6.63 |
| PAT Margin (%) | 4.85 | 1.87 | 3.18 | 6.51 | 4.59 |
| Cash Profit Margin (%) | 8.74 | 6.27 | 6.19 | 9.08 | 7.26 |
| Performance Ratios | |||||
| ROA(%) | 4.72 | 1.60 | 2.98 | 7.54 | 4.82 |
| ROE(%) | 10.03 | 3.66 | 7.09 | 17.98 | 11.07 |
| ROCE(%) | 12.60 | 7.42 | 9.44 | 18.42 | 12.96 |
| Asset Turnover(x) | 0.97 | 0.85 | 0.94 | 1.16 | 1.05 |
| Sales/Fixed Asset(x) | 1.28 | 1.19 | 1.56 | 2.28 | 1.88 |
| Working Capital/Sales(x) | 45.37 | 31.65 | 14.02 | 18.89 | 24.17 |
| Efficiency Ratios | |||||
| Fixed Capital/Sales(x) | 0.78 | 0.84 | 0.64 | 0.44 | 0.53 |
| Receivable days | 56.81 | 52.44 | 40.71 | 31.92 | 34.48 |
| Inventory Days | 70.27 | 90.14 | 87.15 | 68.75 | 77.87 |
| Payable days | 133.15 | 143.42 | 146.47 | 135.85 | 154.56 |
| Valuation Parameters | |||||
| PER(x) | 16.24 | 22.57 | 13.71 | 8.30 | 11.04 |
| PCE(x) | 9.68 | 9.65 | 7.09 | 5.95 | 6.99 |
| Price/Book(x) | 1.66 | 1.16 | 0.93 | 1.38 | 1.16 |
| Yield(%) | 0.14 | 0.22 | 0.29 | 0.22 | 0.30 |
| EV/Net Sales(x) | 1.19 | 0.99 | 0.80 | 0.81 | 0.76 |
| EV/Core EBITDA(x) | 8.19 | 8.60 | 7.88 | 7.80 | 6.33 |
| EV/EBIT(x) | 11.70 | 14.99 | 10.72 | 7.26 | 8.39 |
| EV/CE(x) | 1.46 | 1.10 | 0.94 | 1.23 | 1.05 |
| M Cap / Sales | 0.95 | 0.67 | 0.50 | 0.60 | 0.56 |
| Growth Ratio | |||||
| Net Sales Growth(%) | 12.67 | -3.04 | -9.86 | 31.81 | 1.84 |
| Core EBITDA Growth(%) | 42.54 | 9.88 | -12.07 | 13.25 | 15.71 |
| EBIT Growth(%) | 73.84 | -14.28 | -39.78 | 61.21 | 21.94 |
| PAT Growth(%) | 196.03 | -44.38 | -55.03 | 86.62 | 33.13 |
| EPS Growth(%) | 121.15 | -20.68 | -54.73 | 86.79 | 33.13 |
| Financial Stability Ratios | |||||
| Total Debt/Equity(x) | 0.43 | 0.55 | 0.59 | 0.51 | 0.50 |
| Current Ratio(x) | 1.06 | 1.07 | 1.19 | 1.14 | 1.10 |
| Quick Ratio(x) | 0.61 | 0.53 | 0.56 | 0.55 | 0.58 |
| Interest Cover(x) | 3.99 | 1.96 | 3.42 | 6.26 | 5.26 |
| Total Debt/Mcap(x) | 0.26 | 0.48 | 0.63 | 0.37 | 0.43 |
Compare Financial Ratios of peers of SMS LIFESCIENCES INDIA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SMS LIFESCIENCES INDIA | ₹380.1 Cr | -0.6% | -7.9% | 15.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹415,073.0 Cr | -0% | -3.2% | -5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹175,657.0 Cr | 4% | 5.2% | 11.9% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹134,121.0 Cr | 2.4% | 4.5% | 18.3% | Stock Analytics | |
| CIPLA | ₹118,431.0 Cr | -3.5% | -1.5% | -2.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,944.0 Cr | -3.2% | -3.3% | -10.6% | Stock Analytics | |
SMS LIFESCIENCES INDIA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SMS LIFESCIENCES INDIA | -0.6% |
-7.9% |
15.4% |
| SENSEX | -2.6% |
-1.3% |
7.2% |
You may also like the below Video Courses
